183 related articles for article (PubMed ID: 31568708)
1. Progressive familial intrahepatic cholestasis type-3 and multiple sclerosis: lessons from comorbidity.
De Masi R; Orlando S; De Donno A
Ann Clin Transl Neurol; 2019 Nov; 6(11):2347-2350. PubMed ID: 31568708
[TBL] [Abstract][Full Text] [Related]
2. A female of progressive familial intrahepatic cholestasis type 3 caused by heterozygous mutations of ABCB4 gene and her cirrhosis improved after treatment of ursodeoxycholic acid: a case report.
Qiao F; Ren F; Lu W; Yang H; Mo G; Wang S; Liu L; Xu X
BMC Med Genomics; 2023 Jul; 16(1):171. PubMed ID: 37488596
[TBL] [Abstract][Full Text] [Related]
3. Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
Stättermayer AF; Halilbasic E; Wrba F; Ferenci P; Trauner M
J Hepatol; 2020 Sep; 73(3):651-663. PubMed ID: 32376413
[TBL] [Abstract][Full Text] [Related]
4. ABCB4 disease: Many faces of one gene deficiency.
Sticova E; Jirsa M
Ann Hepatol; 2020; 19(2):126-133. PubMed ID: 31759867
[TBL] [Abstract][Full Text] [Related]
5. Novel ABCB4 mutation in a Chinese female patient with progressive familial intrahepatic cholestasis type 3: a case report.
Wu Z; Zhang S; Zhang L; Li M
Diagn Pathol; 2020 Apr; 15(1):39. PubMed ID: 32321542
[TBL] [Abstract][Full Text] [Related]
6. Ductopenia and cirrhosis in a 32-year-old woman with progressive familial intrahepatic cholestasis type 3: A case report and review of the literature.
Tan YW; Ji HL; Lu ZH; Ge GH; Sun L; Zhou XB; Sheng JH; Gong YH
World J Gastroenterol; 2018 Nov; 24(41):4716-4720. PubMed ID: 30416319
[TBL] [Abstract][Full Text] [Related]
7. Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice.
Aronson SJ; Bakker RS; Shi X; Duijst S; Ten Bloemendaal L; de Waart DR; Verheij J; Ronzitti G; Oude Elferink RP; Beuers U; Paulusma CC; Bosma PJ
J Hepatol; 2019 Jul; 71(1):153-162. PubMed ID: 30935993
[TBL] [Abstract][Full Text] [Related]
8. Reversal of advanced fibrosis after long-term ursodeoxycholic acid therapy in a patient with residual expression of MDR3.
Frider B; Castillo A; Gordo-Gilart R; Bruno A; Amante M; Alvarez L; Mathet V
Ann Hepatol; 2015; 14(5):745-51. PubMed ID: 26256905
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic variability in Tunisian PFIC3 patients harboring a complex genotype with a differential clinical outcome of UDCA treatment.
Khabou B; Mahjoub B; Barbu V; Balhoudi N; Wardani A; Sfar MT; Fakhfakh F
Clin Chim Acta; 2018 Nov; 486():122-128. PubMed ID: 30036524
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a Novel Missense Mutation in
Saleem K; Cui Q; Zaib T; Zhu S; Qin Q; Wang Y; Dam J; Ji W; Liu P; Jia X; Wu J; Bai J; Fu S; Sun W
Dis Markers; 2020; 2020():6292818. PubMed ID: 32626542
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity.
Gordo-Gilart R; Andueza S; Hierro L; Martínez-Fernández P; D'Agostino D; Jara P; Alvarez L
Gut; 2015 Jan; 64(1):147-55. PubMed ID: 24594635
[TBL] [Abstract][Full Text] [Related]
12. Case report: progressive familial intrahepatic cholestasis type 3 with compound heterozygous ABCB4 variants diagnosed 15 years after liver transplantation.
Goubran M; Aderibigbe A; Jacquemin E; Guettier C; Girgis S; Bain V; Mason AL
BMC Med Genet; 2020 Nov; 21(1):238. PubMed ID: 33256620
[TBL] [Abstract][Full Text] [Related]
13. ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
Reichert MC; Lammert F
Semin Liver Dis; 2018 Nov; 38(4):299-307. PubMed ID: 30357767
[TBL] [Abstract][Full Text] [Related]
14. [Progressive familial intrahepatic cholestasis type 3].
Lipiński P; Jankowska I
Dev Period Med; 2018; 22(4):385-389. PubMed ID: 30636238
[TBL] [Abstract][Full Text] [Related]
15. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood.
Jacquemin E; De Vree JM; Cresteil D; Sokal EM; Sturm E; Dumont M; Scheffer GL; Paul M; Burdelski M; Bosma PJ; Bernard O; Hadchouel M; Elferink RP
Gastroenterology; 2001 May; 120(6):1448-58. PubMed ID: 11313315
[TBL] [Abstract][Full Text] [Related]
16. First description of ABCB4 gene deletions in familial low phospholipid-associated cholelithiasis and oral contraceptives-induced cholestasis.
Pasmant E; Goussard P; Baranes L; Laurendeau I; Quentin S; Ponsot P; Consigny Y; Farges O; Condat B; Vidaud D; Vidaud M; Chen JM; Parfait B
Eur J Hum Genet; 2012 Mar; 20(3):277-82. PubMed ID: 21989363
[TBL] [Abstract][Full Text] [Related]
17. A novel etiologic factor of highly elevated cholestanol levels: progressive familial intrahepatic cholestasis.
Küçükçongar Yavaş A; Çavdarlı B; Ünal Uzun Ö; Uncuoğlu A; Gündüz M
J Pediatr Endocrinol Metab; 2020 May; 33(5):665-669. PubMed ID: 32229667
[TBL] [Abstract][Full Text] [Related]
18. Novel mutation in a Chinese patient with progressive familial intrahepatic cholestasis type 3.
Sun HZ; Shi H; Zhang SC; Shen XZ
World J Gastroenterol; 2015 Jan; 21(2):699-703. PubMed ID: 25593501
[TBL] [Abstract][Full Text] [Related]
19. Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4
Wei G; Cao J; Huang P; An P; Badlani D; Vaid KA; Zhao S; Wang DQ; Zhuo J; Yin L; Frassetto A; Markel A; Presnyak V; Gandham S; Hua S; Lukacs C; Finn PF; Giangrande PH; Martini PGV; Popov YV
J Hepatol; 2021 Jun; 74(6):1416-1428. PubMed ID: 33340584
[TBL] [Abstract][Full Text] [Related]
20. Progressive familial intrahepatic cholestasis.
Jacquemin E
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
